Table 2 The association between GBP5 protein expression and clinicopathological parameters of GC
Parameters | GBP5 expression | P | |
|---|---|---|---|
Positive (%) | Negative (%) | ||
Lauren classification | Â | Â | 0.067 |
 Diffuse type | 73 (90.1) | 109 (80.7) |  |
 Intestinal type | 8 (9.9) | 26 (19.3) |  |
Histological type | Â | Â | 0.057 |
 Low/un-differentiated | 75 (90.4) | 109 (80.7) |  |
 High/middle-differentiated | 8 (9.6) | 26 (19.3) |  |
Depth of invasion | Â | Â | 0.042 |
 Muscularis + Serosa | 73 (86.9) | 102 (75.6) |  |
 Mucosa + Submucosa | 11 (13.1) | 33 (24.4) |  |
Growth mode | Â | Â | 0.264 |
 Diffuse/invasive | 63 (75.0) | 109 (81.3) |  |
 Nest | 21 (25.0) | 25 (18.7) |  |
Lymphatic metastasis | Â | Â | 0.882 |
 Positive | 52 (63.4) | 83 (62.4) |  |
 Negative | 30 (36.6) | 50 (37.6) |  |
Peritumor lymphocyte infiltration | Â | 1.000 | |
 Positive | 82 (98.8) | 130 (97.7) |  |
 Negative | 1 (1.2) | 3 (2.3) |  |
Vascular cancer embolus | Â | Â | 0.021 |
 Positive | 53 (63.1) | 63 (47.0) |  |
 Negative | 31 (36.9) | 71 (53.0) |  |
Perineural invasion | Â | Â | 0.334 |
 Positive | 66 (78.6) | 96 (72.7) |  |
 Negative | 18 (21.4) | 36 (27.3) |  |
Extranodal tumor implantation | Â | Â | 0.011 |
 Positive | 11 (13.3) | 5 (3.8) |  |
 Negative | 72 (86.7) | 125 (96.2) |  |